Although further studies are needed to understand the underlying processes, it is evident that the inhibition of JNK, which mediates the protective effects of C66 against diabetes-induced cardiac damage, is based on the suppressed ER stress and increased MT expression in cardiac myocytes. The gene discussed is MAPK8; the disease is diabetes mellitus.